New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S334

Introduced
1/11/22  
Refer
1/11/22  
Report Pass
2/10/22  

Caption

Requires carriers to pass prescription drug savings to consumers.

Impact

The implementation of S334 is anticipated to have significant implications on state laws governing health benefits and insurance practices. If enacted, it would amend existing legislation relating to pharmacy benefits and create a mechanism for consumers to benefit from savings achieved through price negotiations. Health carriers will be required to report annually on their compliance, thus increasing transparency in how savings are utilized. This bill targets issues of affordability in healthcare, especially regarding the rising costs of medications.

Summary

Senate Bill S334 aims to ensure that savings from negotiated prescription drug prices are directly passed on to consumers. Specifically, the bill mandates that carriers, which include health insurance companies and pharmacy benefits managers, use any compensation received from pharmaceutical manufacturers to lower premiums or reduce out-of-pocket costs for consumers at the point of sale. By doing so, the bill seeks to alleviate the financial burden of prescription drugs on individuals covered by health benefits plans.

Sentiment

Discussions surrounding S334 reflect a generally positive sentiment among consumer advocacy groups and healthcare reform supporters, who view it as a necessary measure for enhancing affordability and accessibility within the healthcare system. However, there may be counterarguments regarding the feasibility of enforcing such measures amidst existing contractual obligations between pharmacy benefits managers and manufacturers.

Contention

Despite the overall support for the bill, points of contention may arise concerning the balance of financial incentives in the pharmaceutical industry. Some critics might argue that mandating the pass-through of savings could disrupt existing market dynamics and jeopardize negotiations between manufacturers and pharmacy benefits managers. Additionally, there are concerns regarding the potential administrative burden placed on carriers to comply with new reporting requirements.

Companion Bills

NJ A1745

Same As Requires carriers to pass prescription drug savings to consumers.

Similar Bills

CA AB29

Pharmacy benefit managers.

NJ A1745

Requires carriers to pass prescription drug savings to consumers.

NJ S1390

Requires carriers to pass prescription drug savings to consumers.

CA SB642

Pharmacy benefit management: Prescription Acquisition and Adjudication Agency.

AR HB1620

To Amend The Law Concerning Pharmacy Benefits Managers; And To Regulate Processing And Payment Of Pharmacy Claims.

AR HB1354

To Regulate Pharmacy Benefits Managers; To Amend The Law Concerning The State And Public School Life And Health Insurance Program; And To Amend The Law Concerning Certain Health Benefit Plans.

MA H945

To ensure prescription drug cost transparency and affordability

HI HB24

Relating To Pharmacy Benefit Managers.